Key facts
- NightWare’s last known valuation is $13.0M (Sep 2025).
- It has raised $5.5M across 4 recorded rounds; the latest was Seed Round ($250K) in Feb 2026.
- Notable investors include Rsquared, Minnesota State Board of Investment, Exit 156 Capital, Minnesota Department of Employment and Economic Development, Stony Lonesome Group — 6 tracked in total.
- NightWare has filed 5 Form Ds with the SEC since 2019, most recently Mar 2026 ($250K sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for NightWare
Funding rounds
4 roundsAbout NightWare
Developer of a digital therapeutic device designed to reduce the effects of traumatic nightmares associated with post-traumatic stress disorder. The company's device collects biometric data through integrated sensors and uses machine learning algorithms to track sleep patterns, detect and pinpoint the onset point of a patient's nightmares, and intervene using vibrotactile feedback to arouse the sleeper out of sleep, enabling patients to get better and more restful sleep.
- Sector
- Healthcare
- HQ
- Hopkins, MN, United States
- Founded
- 2015
- Employees
- 10
- Website
- nightware.com/
- Ownership
- Privately Held (backing)
NightWare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NightWare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NightWare in its N-PORT filings yet. We sweep new filings monthly.